|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-11-16
|
|
pubmed:abstractText |
Current goals for the treatment of carcinoma of the maxillary sinus include the preservation of vision, ability to eat, ability to communicate, and appearance as well as cure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1925-32
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11064349-Antimetabolites, Antineoplastic,
pubmed-meshheading:11064349-Combined Modality Therapy,
pubmed-meshheading:11064349-Female,
pubmed-meshheading:11064349-Fluorouracil,
pubmed-meshheading:11064349-Humans,
pubmed-meshheading:11064349-Male,
pubmed-meshheading:11064349-Maxillary Sinus Neoplasms,
pubmed-meshheading:11064349-Middle Aged,
pubmed-meshheading:11064349-Neoplasm Invasiveness,
pubmed-meshheading:11064349-Neoplasm Recurrence, Local,
pubmed-meshheading:11064349-Otorhinolaryngologic Surgical Procedures,
pubmed-meshheading:11064349-Radiotherapy Dosage,
pubmed-meshheading:11064349-Retrospective Studies,
pubmed-meshheading:11064349-Survival Rate
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma.
|
|
pubmed:affiliation |
Department of Otolaryngology, Jichi Medical School, Tochigi, Japan. hiroshi@jichi.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
